Neuro-Oncology · 2020 · 70 citations · 76 references
MedicineNeuroscienceOncologyMolecular OncologyNeuro-oncologyPediatric OncologyBrain TumorsCentral Nervous System TumorsGlial PathologyNeuro-oncologic PathologyPediatric Brain TumorsPediatric Neuro-oncologyConsensusKnockout Mouse ModelsNeurofibromatosis Type 1Neurofibromatosis-associated TumorsPanel ConsensusPediatric High-grade GliomaPediatric Low-grade GliomaTransgenic Mouse Models
Gliomas are the most common primary central nervous system tumors occurring in children and adults with neurofibromatosis type 1 (NF1). Over the past decade, discoveries of the molecular basis of low-grade gliomas (LGGs) have led to new approaches for diagnosis and treatments. However, these new understandings have not been fully applied to the management of NF1-associated gliomas. A consensus panel consisting of experts in NF1 and gliomas was convened to review the current molecular knowledge of NF1-associated low-grade "transformed" and high-grade gliomas; insights gained from mouse models of NF1-LGGs; challenges in diagnosing and treating older patients with NF1-associated gliomas; and advances in molecularly targeted treatment and potential immunologic treatment of these tumors. Next steps are recommended to advance the management and outcomes for NF1-associated gliomas.
76
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley et al. · Nature · 2014 · 6.6K citations · Full text
Life Sciences, Immunology, Pathology +14
DNA methylation-based classification of central nervous system tumours
David Capper, David Jones, Martin Sill et al. · Nature · 2018 · 3.1K citations · Full text
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
David Jones, Barbara Hutter, Natalie Jäger et al. · Nature Genetics · 2013 · 835 citations · Full text